Mouse Models of Pain in Sickle Cell Disease

Area of Science:

• Hematology
• Pain Medicine
• Genetics

Background:

• Sickle cell disease (SCD) is a prevalent genetic blood disorder causing significant, debilitating pain.
• Pain in SCD can be acute, often during vaso-occlusive crisis (VOC), or chronic, affecting a large patient population.
• Current pain management relies heavily on opioids, which have substantial long-term side effects, highlighting a critical unmet need.

Purpose of the Study:

• To investigate the mechanisms of pain in sickle cell disease (SCD).
• To explore the utility of humanized transgenic mouse models for studying SCD-related pain.
• To facilitate the development of novel, targeted analgesic therapies for SCD pain.

Main Methods:

• Utilized humanized transgenic mice expressing human sickle hemoglobin.
• Observed and analyzed pain phenotypes and pathobiology in these mouse models.
• Compared findings in mice to known features of pain in human SCD patients.

Main Results:

• Humanized transgenic mice exhibited pain and pathobiological features mirroring those seen in human SCD patients.
• These mouse models successfully recapitulated key aspects of SCD pain and disease mechanisms.
• The models provide a viable platform for preclinical research into SCD pain.

Conclusions:

• Humanized transgenic mice are valuable preclinical models for studying sickle cell disease pain.
• These models hold promise for advancing the understanding of SCD pain mechanisms.
• The models can aid in the development and testing of innovative pain management strategies for SCD.